Company intelligence / Profile preview

Genescient Corporation

Fountain Valley, California, United Statesgenescient.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Genescient is developing novel therapeutics targeting the genetics underlying chronic diseases of aging, leveraging proprietary evolutionary genomics and high-throughput screening. No clinical results are currently available in the public domain

Therapeutic areas: Other
Modalities: Not explicitly stated; likely small molecules and/or genomics-driven therapeutics based on focus on evolutionary genomics and drug discovery for chronic diseases of aging
Industry: Biotech

Drug pipeline

2 assets

MX100A

Preclinical

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Genescient Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genescient Corporation.

Explore the full profile